The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. Stereotactic body radiation therapy (SBRT) preserves ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, according to ...

In recent decades, there have been enormous developments in cancer treatment. In the past, most patients received chemotherapy, a broad treatment that also damages healthy cells, but for several years ...

Phase III trial presented at ASTRO in San Francisco finds five-treatment regimen poised to become new standard of care. The principal investigator of the trial, Ellis is a radiation oncologist and ...

Recent developments in oncology have increasingly focused on precision, non-invasive treatment modalities and structured multidisciplinary care. Within this clinical context, Dr Neeraj Dhingra, ...